Product Images Increlex

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Increlex NDC 15054-1040 by Ipsen Biopharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure - increlex 01

Figure - increlex 01

Figure 1 - increlex 02

Figure 1 - increlex 02

Figure 2 - increlex 03

Figure 2 - increlex 03

Figure 3 - increlex 04

Figure 3 - increlex 04

Figure 4 - increlex 05

Figure 4 - increlex 05

Figures 5 and 6 - increlex 06

Figures 5 and 6 - increlex 06

Figure 7 - increlex 07

Figure 7 - increlex 07

Figure 8 - increlex 08

Figure 8 - increlex 08

Figure - increlex 09

Figure - increlex 09

Figure - increlex 10

Figure - increlex 10

Figure - increlex 11

Figure - increlex 11

Figure - increlex 12

Figure - increlex 12

Figure A - increlex 13

Figure A - increlex 13

Figure B - increlex 14

Figure B - increlex 14

PRINCIPAL DISPLAY PANEL - 40 mg Vial Carton - increlex 15

PRINCIPAL DISPLAY PANEL - 40 mg Vial Carton - increlex 15

This text contains information about a medication called "Increlex," which is a type of injection containing a combination of ingredients, including mecasermin and somatropin, used for subcutaneous use and should be kept refrigerated. The medication is available in multi-use vials and the unused material should be discarded after more than 30 days of the vials being opened. The product is distributed by Ispen Bopharmaceuticals, Inc. and the vials contain 40mg of medication each.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.